SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-24-051381
Filing Date
2024-06-10
Accepted
2024-06-10 18:00:25
Documents
1
Period of Report
2024-06-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-66263.html 4  
1 PRIMARY DOCUMENT marketforms-66263.xml 4 4235
  Complete submission text file 0001213900-24-051381.txt   5881
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Issuer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 508 WRANGLER DRIVE, SUITE 100 COPPELL TX 75019
Business Address
Smith Cynthia (Reporting) CIK: 0001609480 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36694 | Film No.: 241034006